Results 1 to 10 of about 15,516 (152)

Invasive Pulmonary Aspergillosis

Journal of Fungi, 2023
Invasive pulmonary aspergillosis is growing in incidence, as patients at risk are growing in diversity. Outside the classical context of neutropenia, new risk factors are emerging or newly identified, such as new anticancer drugs, viral pneumonias and ...
Marie-Pierre Ledoux, Raoul Herbrecht
doaj   +4 more sources

Mechanistic Basis of Super-Infection: Influenza-Associated Invasive Pulmonary Aspergillosis

Journal of Fungi, 2022
Influenza infection is a risk factor for invasive pulmonary aspergillosis in both immunocompetent and immunocompromised hosts. The purpose of this review is to highlight the epidemiology of influenza-associated invasive pulmonary aspergillosis and the ...
Keven Mara Robinson
doaj   +3 more sources

Subacute invasive pulmonary aspergillosis

Journal of Advanced Lung Health, 2021
Subacute invasive pulmonary aspergillosis (IPA) is an indolent cavitating infectious process which can mimic other chronic lung infections such as tuberculosis.
Ravindran Chetambath
doaj   +2 more sources

Rare concurrent invasive pulmonary aspergillosis in a critically Ill patient with hemorrhagic fever with renal syndrome: a case report [PDF]

BMC Infectious Diseases
Background Hantavirus infection frequently results in hemorrhagic fever with renal syndrome, which may be fatal in certain instances. invasive pulmonary aspergillosis is a rare concurrent symptom that requires considerable attention from clinicians. Case
Weiwei Yan, Alin Sun, Liming Wang, Jihong Zhang, Peng Chen   +4 more
doaj   +2 more sources

Invasive pulmonary aspergillosis [PDF]

Revista Clínica Española (English Edition), 2020
AbstractInvasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ transplantation, inherited or acquired immunodeficiency, administration of steroids or other immunosuppressive agents including monoclonal antibodies and new small ...
L A, Fernández-Bermejo, G, Ramírez-Olivencia   +1 more
  +10 more sources

Co-infection of active pulmonary tuberculosis and invasive pulmonary aspergillosis following a liver transplant: a case report [PDF]

BMC Infectious Diseases
Background We report a rare case of co-infection involving pulmonary tuberculosis and invasive aspergillosis following a liver transplant. Case presentation A 25-year-old female housewife immigrant from Afghanistan, who had autoimmune hepatitis and ...
Sara Abolghasemi, Masoud Mardani, Maryam Valikhani, Amirhassan Rabbani, Mahmood Amiri   +4 more
doaj   +2 more sources

Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]

Current Medical Mycology, 2022
Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed, Kausar Jabeen, Joveria Farooqi, Hammad Niamatullah, Aisha Fareed Siddiqui, Safia Awan, Alishah Akbar, Irfan Muhammad   +7 more
doaj   +1 more source

Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study

Diagnostics, 2023
Invasive pulmonary aspergillosis is associated with high mortality. For diagnosis, galactomannan-antigen in serum and bronchoalveolar lavage fluid is recommended, with higher sensitivity in bronchoalveolar lavage fluid.
Kathrin Rothe, Miriam Dibos, Stefanie J. Haschka, Roland M. Schmid, Dirk Busch, Sebastian Rasch, Tobias Lahmer   +6 more
doaj   +1 more source

Invasive pulmonary aspergillosis

Expert Review of Anti-infective Therapy, 2005
In susceptible patients, invasive aspergillosis has a high incidence and a mortality of up to 80%. The diagnosis of this condition is difficult, especially in the early stages of the disease and, as a consequence, antifungal therapy, despite its expense and toxicity, is often initiated empirically.
S R, Doffman, S G, Agrawal, Jeremy S, Brown   +2 more
  +6 more sources

Successful treatment of invasive tracheobronchial pulmonary aspergillosis with venovenous extracorporeal membrane oxygenation and combined systemic, intratracheal instillation of liposomal amphotericin B: a case report

Journal of Medical Case Reports, 2022
Background Invasive pulmonary Aspergillus and invasive bronchial aspergillosis is a life-threatening opportunistic fungal infection that predominantly affects immunocompromised hosts.
Shuku Sato, Wataru Kamata, Kiyomitsu Fukaguchi, Shun Tsunoda, Tadashi Kamio, Hiroshi Koyama, Hideyasu Sugimoto, Yotaro Tamai   +7 more
doaj   +1 more source